JP2000508301A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000508301A5 JP2000508301A5 JP1997535795A JP53579597A JP2000508301A5 JP 2000508301 A5 JP2000508301 A5 JP 2000508301A5 JP 1997535795 A JP1997535795 A JP 1997535795A JP 53579597 A JP53579597 A JP 53579597A JP 2000508301 A5 JP2000508301 A5 JP 2000508301A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19613972A DE19613972A1 (de) | 1996-04-09 | 1996-04-09 | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
| DE19613972.4 | 1996-04-09 | ||
| PCT/EP1997/001569 WO1997037653A1 (de) | 1996-04-09 | 1997-03-27 | Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000508301A JP2000508301A (ja) | 2000-07-04 |
| JP2000508301A5 true JP2000508301A5 (enExample) | 2004-10-28 |
| JP4257870B2 JP4257870B2 (ja) | 2009-04-22 |
Family
ID=7790774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53579597A Expired - Fee Related JP4257870B2 (ja) | 1996-04-09 | 1997-03-27 | ヒマシ油を基とする注射用アベルメクチン含有およびミルベマイシン含有調剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6063394A (enExample) |
| EP (1) | EP0896534B1 (enExample) |
| JP (1) | JP4257870B2 (enExample) |
| CN (1) | CN1095662C (enExample) |
| AT (1) | ATE285233T1 (enExample) |
| AU (1) | AU718807B2 (enExample) |
| BR (1) | BR9708540B1 (enExample) |
| CA (1) | CA2251087C (enExample) |
| DE (2) | DE19613972A1 (enExample) |
| ES (1) | ES2235230T3 (enExample) |
| NZ (1) | NZ332224A (enExample) |
| PT (1) | PT896534E (enExample) |
| WO (1) | WO1997037653A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
| RS49838B (sr) * | 1997-12-03 | 2008-08-07 | Merck& Co. Inc., | Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje |
| US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
| GB9827727D0 (en) * | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
| US20050009762A1 (en) * | 2003-06-06 | 2005-01-13 | Strobel Michael Albert | Application of water and organic solvent soluble ivermectin for topical and oral use |
| CN1275589C (zh) * | 2002-05-31 | 2006-09-20 | 王玉万 | 含抗寄生虫药物的缓释注射剂 |
| US7262214B2 (en) | 2003-02-26 | 2007-08-28 | Merial Limited | 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases |
| US20050271459A1 (en) * | 2004-06-03 | 2005-12-08 | World Wide Stationery Mfg. Co., Ltd. | Interlocking ring tip formations for paired ring members of a ring binder mechanism |
| NZ534939A (en) * | 2004-08-26 | 2007-04-27 | Bomac Research Ltd | Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility |
| DE102004053964A1 (de) * | 2004-11-09 | 2006-05-11 | Bayer Healthcare Ag | Mittel gegen Demodikose |
| CN101842079B (zh) * | 2007-08-31 | 2012-09-05 | 阿基米德开发有限公司 | 非水性药物组合物 |
| US20100022469A1 (en) * | 2008-06-24 | 2010-01-28 | Majid Razzak | Anthelminthic formulations |
| CA2750626C (en) | 2009-02-16 | 2013-10-01 | Pfizer Inc. | High dosage doramectin formulation |
| CN101773467B (zh) * | 2010-01-20 | 2015-09-09 | 北京大北农动物保健科技有限责任公司 | 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法 |
| KR101805087B1 (ko) * | 2010-09-16 | 2017-12-05 | 주식회사 엘지화학 | 높은 방부력을 제공하는 오일 주사 제형 |
| WO2013137748A1 (en) | 2012-03-13 | 2013-09-19 | Bayer New Zealand Limited | Long acting compositions |
| WO2016022066A1 (en) | 2014-08-04 | 2016-02-11 | Jerry Tan Eye Surgery Pte Ltd | Pharmaceutical compositions for demodex related blepharitis and eyelid crusting |
| AU2018385766B2 (en) | 2017-12-15 | 2022-12-01 | Tarsus Pharmaceuticals, Inc. | Isoxazoline parasiticide formulations and methods for treating blepharitis |
| WO2020180635A1 (en) * | 2019-03-01 | 2020-09-10 | Boehringer Ingelheim Animal Health USA Inc. | Injectable clorsulon compositions, methods and uses thereof |
| US12502377B2 (en) | 2019-04-04 | 2025-12-23 | Tarsus Pharmaceuticals, Inc. | Method of eradicating ticks that attach to humans using lotilaner formulations |
| US11638714B2 (en) | 2020-11-10 | 2023-05-02 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
| US11077134B1 (en) | 2020-11-10 | 2021-08-03 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
| US11918572B2 (en) * | 2022-01-28 | 2024-03-05 | Rebel Medicine Inc | Pharmaceutical compositions for treating pain |
| CN114642632A (zh) * | 2022-02-25 | 2022-06-21 | 河北科技大学 | 一种莫西克汀注射液及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4914624A (enExample) * | 1972-06-08 | 1974-02-08 | ||
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4199569A (en) * | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
| NZ197796A (en) * | 1980-08-04 | 1984-11-09 | Merck & Co Inc | Stabilised aqueous formulations containing ivermectin |
| NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
| DE3727648A1 (de) * | 1987-08-19 | 1989-03-02 | Bayer Ag | Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung |
| US5510117A (en) * | 1989-03-09 | 1996-04-23 | Micro-Pak, Inc. | Entrapment vehicle and method |
| EP0393890B1 (en) * | 1989-04-11 | 1992-08-12 | Pfizer Limited | Injectable compositions containing 25-cyclohexyl-avermectin b1 |
| NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
| DE69208765T2 (de) * | 1991-07-23 | 1996-09-26 | American Cyanamid Co | Stabile Zusammensetzungen für parenterale Verabrechung und ihre Verwendung |
| EP0535734B1 (en) * | 1991-09-30 | 1999-06-02 | Merck & Co. Inc. | Long acting injectable formulations containing hydrogenated castor oil |
| AU5330294A (en) * | 1992-10-21 | 1994-05-09 | Micro Vesicular Systems, Inc. | Entrapment vehicle and method |
-
1996
- 1996-04-09 DE DE19613972A patent/DE19613972A1/de not_active Withdrawn
-
1997
- 1997-03-27 BR BRPI9708540-5A patent/BR9708540B1/pt active IP Right Grant
- 1997-03-27 WO PCT/EP1997/001569 patent/WO1997037653A1/de not_active Ceased
- 1997-03-27 AU AU25066/97A patent/AU718807B2/en not_active Expired
- 1997-03-27 US US09/155,836 patent/US6063394A/en not_active Expired - Lifetime
- 1997-03-27 EP EP97916406A patent/EP0896534B1/de not_active Expired - Lifetime
- 1997-03-27 CN CN97193700A patent/CN1095662C/zh not_active Expired - Lifetime
- 1997-03-27 ES ES97916406T patent/ES2235230T3/es not_active Expired - Lifetime
- 1997-03-27 DE DE59712134T patent/DE59712134D1/de not_active Expired - Lifetime
- 1997-03-27 PT PT97916406T patent/PT896534E/pt unknown
- 1997-03-27 AT AT97916406T patent/ATE285233T1/de active
- 1997-03-27 JP JP53579597A patent/JP4257870B2/ja not_active Expired - Fee Related
- 1997-03-27 CA CA002251087A patent/CA2251087C/en not_active Expired - Lifetime
- 1997-03-27 NZ NZ332224A patent/NZ332224A/en not_active IP Right Cessation